{"database": "openregs", "table": "federal_register", "rows": [["2013-02293", "Draft Guidance for Industry on Enrichment Strategies for Clinical Trials To Support Approval of Human Drugs and Biological Products; Extension of Comment Period", "Notice", "The Food and Drug Administration (FDA) is extending the comment period for the draft guidance for industry entitled \"Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products\" that appeared in the Federal Register of December 17, 2012 (77 FR 74670). In the document, FDA announced the availability of this draft guidance and explained that the comment period would close on February 15, 2013. The Agency is taking this action to allow interested persons additional time to submit comments.", "2013-02-04", 2013, 2, "https://www.federalregister.gov/documents/2013/02/04/2013-02293/draft-guidance-for-industry-on-enrichment-strategies-for-clinical-trials-to-support-approval-of", "https://www.govinfo.gov/content/pkg/FR-2013-02-04/pdf/2013-02293.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is extending the comment period for the draft guidance for industry entitled \"Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products\" that appeared in the Federal...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2013-02293"], "units": {}, "query_ms": 0.6011349614709616, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}